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Cysticercosis is an increasingly important disease in
the United States, but information on the occurrence of
related deaths is limited. We examined data from California
death certificates for the 12-year period 1989–2000.  A total
of 124 cysticercosis deaths were identified, representing a
crude 12-year death rate of 3.9 per million population (95%
confidence interval [CI] 3.2 to 4.6). Eighty-two (66%) of the
case-patients were male; 42 (34%) were female. The medi-
an age at death was 34.5 years (range 7–81 years). Most
patients (107, 86.3%) were foreign-born,  and 90 (72.6%)
had emigrated from Mexico. Seventeen (13.7%) deaths
occurred in U.S.-born residents. Cysticercosis death rates
were higher in Latino residents of California (13.0/106) than
in other racial/ethnic groups (0.4/106), in males (5.2/106)
than in females (2.7/106), and in persons >14 years of age
(5.0/106). Cysticercosis is a preventable cause of prema-
ture death, particularly among young Latino persons in
California and may be a more common cause of death in
the United States than previously recognized. 
C
ysticercosis, an infection caused by the larval form of
the pork tapeworm, Taenia solium, is recognized as an
increasingly important cause of severe neurologic disease
in the United States (1–3). In the typical transmission
cycle, eggs from the adult tapeworm are shed in the feces
of a human carrier and subsequently ingested by pigs, the
usual intermediate host (4). Larvae emerge from the eggs,
penetrate the intestinal mucosa and disseminate through
the bloodstream to various tissues where the larval stage or
cysticercus develops. The cycle is completed when
humans, the only naturally infected definitive host, con-
sume raw or undercooked pork containing cysticerci,
which attach to the small bowel and develop into adult
tapeworms, thereby completing the cycle. However,
humans may also become infected with the larval stage
when eggs, which are directly infectious, are ingested, typ-
ically through contaminated food or water. Neurocysticer-
cosis, the most severe form of the disease, occurs when
larvae invade tissue of the central nervous system. While
cysticercosis in the United States principally affects immi-
grants from cysticercosis-endemic areas of Latin America,
it has been increasingly recognized in U.S.-born residents
as well (5–7).
Despite the growing importance of cysticercosis, sur-
veillance systems for cysticercosis have rarely been imple-
mented (6,8), and the true impact of the disease in the
United States is largely unknown. Although several case
series have been published (1,2,9–11), these have been
facility-based efforts and, consequently, may not provide
an accurate measure of either the incidence or severity of
the disease. Such facility-based reports have suggested that
deaths from cysticercosis in the United States are uncom-
mon. Although population-based data would provide a
more accurate assessment of cysticercosis death rates, such
data are scarce. To measure cysticercosis-related death
rates in California, we reviewed state mortality records for
the 12-year period 1989–2000.
Methods
Data Source
Data on deaths were obtained from the State of
California, Center for Health Statistics, Office of Vital
Records. Completion of a death certificate is required by
state law. All death certificates in California require the
assignment of a cause or sequence of events leading to
death as determined by the attending physician. If a physi-
cian is not in attendance, or the death is accidental or
occurs under suspicious circumstances, cause of death is
determined by the local coroner or medical examiner.
Completed death certificates are transmitted from county
jurisdictions to the California Department of Health
Services, where the causes or sequence of events for each
death record are keyed into a computer to create an input
data file, which is subsequently sent to the National Center
for Health Statistics (NCHS), which produces codes for
both the underlying cause of death and multiple cause for
each death record.  The resulting coded file is then returned
to the California Department of Health Services, Office of
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 3, March 2004 465
Cysticercosis-related Deaths,
California
Frank J. Sorvillo,* Lawrence Portigal,†  Christopher DeGiorgio,* Lisa Smith,* 
Stephen H. Waterman,‡ George W. Berlin,* and Lawrence R. Ash* 
*University of California, Los Angeles, California, USA; †Office of
Vital Records, State of California, Sacramento, California, USA;
and ‡Centers for Disease Control and Prevention, Atlanta,
Georgia, USAVital Records. Data from the State of California’s Multiple
Cause of Death Files for the 12-year period 1989–2000
were searched for persons for whom cysticercosis (ICD-9
code 123.1 for years 1989–1998, and ICD-10 code B69 for
years 1999 and 2000) was listed as a cause of death.
Additional information extracted from the death record
included age, gender, race/ethnicity, level of education,
country of birth, place of death, and date of death. 
Data Analysis
Cysticercosis death rates per million population were
calculated for California and for its major counties by
using mid-period population estimates (1994). Population
data were obtained from the Department of Finance,
Demographic Research Unit, State of California. Crude
cysticercosis death rates and 95% confidence intervals
were computed according to age, gender, race/ethnicity,
and county of residence. Rate ratios and 95% confidence
intervals were also calculated. The chi-square, Fisher
exact, and Student t tests were employed when appropriate
to assess apparent differences. 
Results
Atotal of 124 cysticercosis deaths (mean 10.3 per year)
were identified over the 12-year study period, representing
a crude 12-year death rate of 3.9 per million population
(95% confidence interval [CI] 3.2 to 4.6). Latino residents
accounted for 115 (92.7%) of the total deaths recorded,
while 5 (4.0%) were white, 3 (2.4%) were Asian, and 1
(0.8%) was black (Table 1). Eighty-two (66.1%) were
male; 42 (33.9%) were female. The mean age at death was
39.9 years (range 7–81 years). Most case-patients (107,
86.3%) were born outside the United States, and 90
(72.6%) had emigrated from Mexico. All three fatal cases
in Asians were in male immigrants >55 years of age.
Cysticercosis was listed as the underlying cause of death
for 92 (74.2%) of the patients. 
Crude cysticercosis death rates are presented in Table 2.
Rates were highest in Latino persons (13.0/106, 95% CI
10.6 to 15.3) compared with those for other racial/ethnic
groups (0.4/106, 95% CI 0.1 to 0.7), in males (5.2/106, 95%
CI 4.0 to 5.7) relative to females (2.7/106, 95% CI 1.9 to
3.5), and in persons >14 years of age (5.0/106, 95% CI 4.2
to 5.9). Cysticercosis deaths varied by year with the great-
est number (16 deaths) observed in 1992 (Figure). The
highest cysticercosis death rates were in the counties of
Los Angeles (7.7/106), Riverside (6.0/106), and Ventura
(5.7/106). More than half of the deaths (70) were among
Los Angeles County residents. 
Seventeen cysticercosis deaths occurred in U.S.-born
residents, representing 14% of all cysticercosis deaths.
U.S.-born patients with fatal cysticercosis had higher edu-
cational levels (p = 0.02), were older (mean age 49.1 years
versus 38.4 years, p < 0.05), and were more likely to be
male (but this difference was not statistically significant)
(Table 3). Although 71% of U.S.–born deaths occurred
among Latino persons, this figure was lower than the pro-
portion for foreign-born Latino residents (p < 0.01).
Principal coexisting conditions listed as contributing to
death included hydrocephalus in 45 (36.3%) persons and
epilepsy or convulsions in 20 (16.1%) deaths. Reported
place of death included inpatient facility (69%), emer-
gency room or outpatient clinic (10%), nursing home,
(9%) and residence (9%).
Discussion
Our findings indicate that cysticercosis is an important
and preventable cause of premature death in California,
particularly among Latino youth, and the disease may be a
more common cause of death in the United States than pre-
viously recognized. Although fatal cysticercosis principal-
ly affects Hispanic immigrants, our findings suggest that
this larval tapeworm causes infection and death in U.S.-
born residents as well. 
Published studies from large facility-based case series
have reported that the cysticercosis death rate is relatively
low (Table 4). In a review of records from four county hos-
pitals in Los Angeles County, Richards and colleagues
identified 497 cysticercosis cases from 1973 to 1983 (1).
The overwhelming majority of patients were of Latino eth-
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Table 1. Demographic characteristics of 124 patients with fatal 
cysticercosis in California, 1989–2000 
Characteristic  No.  % 
Sex     
Male  82  66.1 
Female  42  33.9 
Race/Ethnicity     
White  5  4.0 
Black  1  0.8 
Latino  115  92.7 
Asian/Pacific Islander  3  2.4 
Age group (y)     
5–14  3  2.4 
15–24  25  20.2 
25–34  34  27.4 
35–44  16  12.9 
45–54  20  16.1 
55–64  10  8.1 
>65  16  12.9 
Educational level (y)     
<12   83  66.9 
12   24  19.4 
>12   17  13.7 
Country of birth     
United States  17  13.7 
Mexico  90  72.6 
Other  17  13.7 nicity (95%). The observed death rate was 2.2% (11 case-
patients). Another study found three (1.3%) fatal cases of
cysticercosis among 238 cases identified in a Los Angeles
hospital from 1981 to 1986 (9). All cases were in Latino
patients. Athird Los Angeles report involving 230 patients
observed two deaths (<1%) in a population composed pre-
dominantly of immigrants from Latin America (10). A
review of neurocysticercosis records from Ben Taub
Hospital in Houston, Texas, over the 6-year period
1986–1991 identified 112 cases; 97% were in Latino
patients, who were principally from Mexico (2). Deaths
were uncommon; one patient died. He also had ventricular
disease with shunt malfunction complicated by staphylo-
coccal and candidal infections. Forty-seven cases of neuro-
cystcercosis were reported among children whose cases
were diagnosed at Children’s Memorial Hospital in
Chicago from 1986 to 1994 (12). A total of 45 (96%)
patients were Latino; however, 19 (42%) were reportedly
born in the United States. No deaths were observed in
these pediatric case-patients. In a study from Children’s
Hospital in Los Angeles covering the period 1980–1986,
no deaths occurred among 52 children with neurocysticer-
cosis (11). A total of 51 (98.1%) patients were Latino, 29
(57%) of whom were born in the United States. An
unweighted estimate of death rates across these studies
suggests a case-fatality rate of <1%. However, such facili-
ty-based studies, while providing valuable information,
have substantial limitations and may have underestimated
the impact of cysticercosis as a cause of death. Limited
data from a surveillance system established in Los Angeles
County from 1988 to 1990 showed a mortality rate of near-
ly 6% (8 of 138 incident cases); however, this observation
was based on small numbers (6).
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Table 2. Crude cysticercosis death rates by gender, race/ethnicity, and age group and respective rate ratios, California, 1989–2000 
  No.  Rate/10
6 (95% CI)
a  RR
b (95% CI) 
Sex       
Male  82  5.2 (4.0 to 5.7)  1.9 (1.3 to 2.8) 
Female  42  2.7 (1.9 to 3.5)  Referent 
Race/Ethnicity       
White  5  0.3 (0.04 to 0.5)  Referent 
Black  1  0.5 (0 to 1.3)  1.7 (0.2 to 14.3) 
Latino  115  13.0 (10.6 to 15.3)  43.3 (17.7 to 106.1) 
Asian/Pacific Islander  3  0.9 (0 to 2.0)  3.0 (0.7 to 12.6) 
Age group (y)       
5–14  3  0.6 (0 to 1.4)  Referent 
15–24  25  5.8 (3.5 to 8.1)  9.7 (2.9 to 32.0) 
25–34  34  6.1 (4.1 to 8.2)  10.2 (3.2 to 33.1) 
35–44  16  3.1 (1.6, 4.6)  5.2 (1.5 to 17.7) 
45–54   20  5.7 (3.2 to 8.3)  9.5 (2.8 to 32.0) 
55–64  10  4.4 (1.7 to 7.1)  7.3 (2.0 to 26.6) 
>65   16  4.7 (2.4 to 7.1)  7.8 (2.3 to 26.9) 
a12-year rate calculated by using midpoint (1994) population data.  
bRate ratio. 
Figure. Cysticercosis deaths in California by year, 1989–2000,
from state mortality data.
Table 3. Comparison of selected characteristics of patients born 
in the United States and those born outside the United States 
with fatal cysticercosis, California, 1989–2000 
  U.S.-born
a no (%)  Non–U.S.-born
a no. (%) 
Sex     
Male  13 (76.5)  69 (64.5) 
Female  4 (23.5)  38 (35.5) 
Race/Ethnicity     
White  4 (23.5)  1 (0.9) 
Latino  12 (70.6)  103 (96.3) 
Black  1 (5.9)  0 
Asian/Pacific Islander  0  3 (2.8) 
Age group     
5–14  0  3 (2.4) 
15–24  3 (17.7)  22 (20.6) 
25–34  2 (11.8)  32 (29.9) 
35–44  3 (17.7)  13 (12.2) 
45–54  1 (5.9)  19 (17.8 
55–64  2 (11.8)  8 (7.5) 
>64  6 (35.3)  10 (9.3) 
Educational level (y)     
<12  7 (41.2)  76 (71.0) 
12  5 (29.4)  19 (17.8) 
>12  5 (29.4)  12 (11.2) 
aN = 17. Both the location of the infection and the number of lar-
vae may have an impact on whether the disease is fatal.
Extraparenchymal infection, particularly intraventricular
disease with resultant hydrocephalus, has been associated
with a poorer prognosis (13–15). We found that more than
one third of patients who died had concurrent hydro-
cephalus, suggesting intraventricular location of cysts. In
addition, ingesting a large number of eggs may cause an
overwhelming, fatal acute infection with numerous larvae
and notable central nervous system pathology. Cases of
racemose cysticercosis, a phenomenon in which cysticerci
continue to grow and spread through tissue, may also have
a poor prognosis (16).
Our data suggest that, although uncommon, cysticerco-
sis-related deaths routinely occur among persons born in
the United States, a phenomenon that has not been previ-
ously reported. Such deaths in U.S.-born residents may
reflect low-level endemic transmission within the United
States. Confirmed cysticercosis among persons who have
never traveled outside the United States has been repeated-
ly documented over the past 20 years (1,5,6) and can often
be traced to a tapeworm carrier among household members
or other close personal contacts. Cysticercosis acquired in
the United States may also have been transmitted through
consuming imported or local produce contaminated with T.
solium eggs. Taenia eggs can survive for long periods in
the environment (17), and human feces used as fertilizer or
contaminated water employed for irrigation can contami-
nate crops prior to importation. 
Alternatively, cysticercosis among U.S.-born persons
may reflect travel-related exposure and infection. Travel
by U.S. residents to cysticercosis-endemic areas is com-
mon, and exposure to food and water contaminated with
the eggs of T. solium may readily occur. The recovery of
Taenia  spp. eggs from several varieties of vegetables
obtained in local markets in the northeastern Mexican state
of Tamaulipas, which borders the United States, has been
reported (18). Although probable travel-associated cys-
ticercosis has previously been documented (6), neither the
frequency nor the risk factors for travel-related cysticerco-
sis have been studied. 
Nearly one half of those who died of cysticercosis in
our study were 15–34 years of age. This represents a heavy
toll among persons in young, highly productive age
groups. Such a phenomenon is uncommon for most infec-
tious diseases, which typically cause higher rates of death
in the very young and the elderly (19). 
Observed death rates were highest in Los Angeles,
Riverside, and Ventura counties. This finding may reflect
the fact that residents of these jurisdictions include sub-
stantial numbers of immigrants from cysticercosis-endem-
ic areas, particularly Mexico and other areas of Latin
America. 
Our data, although population-based, likely underesti-
mate cysticercosis deaths for several reasons. Cysticercosis
must be recognized and diagnosed for it to be listed on the
death certificate. This would require confirmation of infec-
tion through biopsy, autopsy or specialized serologic test-
ing (20). Consequently, some cases of fatal cysticercosis
likely are undiagnosed and unrecognized; this would result
in the miscoding of cysticercosis-related deaths as other
conditions. For this reason, death records likely possess
moderate sensitivity for identification of true cysticercosis
deaths. Our findings demonstrate the benefits of using mul-
tiple cause of death data instead of the traditional underly-
ing cause of death data alone for estimating the extent of
cysticercosis deaths. An additional 32 (26%) cases were
identified by using multiple-cause coded files. 
Using death certificates to assess the impact of disease
has both advantages and limitations. Since submitting a
death certificate is required by state law, virtually all
deaths are ascertained and registered. The use of death
records, therefore, provides population-based data that
avoid the potential biases of facility-based or other non-
population-based data sources. Death records also provide
a good measure of disease trends over time and can be use-
ful in making comparisons between geographic regions.
Mortality data can also help indicate disease severity and
contribute to measures of disease impact. Limitations of
mortality data include the following: inaccurate informa-
tion due to errors in recording cause of death; coding
errors; and misclassification of race/ethnicity (21–23).
Recognizing that deaths from cysticercosis represent only
a small fraction of total disease is also important. Finally,
both census data and intercensus population estimates used
to calculate rates may contain inaccuracies. For these rea-
sons, our estimate of the cysticercosis death rate must be
interpreted with caution.
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Table 4. Hospital-based cysticercosis case series and observed mortality rates, United States 
Location  No. cases  No. deaths (%)  Y  Reference 
Los Angeles  497  11 (2.2)  1973–1983  1 
Los Angeles  238  3 (1.3)  1981–1986  9 
Los Angeles  230  2 (0.9)  1981
a  10 
Houston  112  1 (0.9)  1986–1991  2 
Chicago  47  0  1986–1994  12 
Los Angeles  52  0  1980–1986  11 
aRange of years not provided. Cysticercosis is a preventable fecal-oral transmitted
infection that can cause severe neurologic disease and
death and result in substantial cost to the healthcare system.
Additional information is needed on the prevalence and
incidence of cysticercosis and on cysticercosis-related
deaths in the United States. To better define the extent of
cysticercosis, state and local health authorities should con-
sider instituting a requirement for the mandatory reporting
of this infection. Such surveillance systems should include
aggressive efforts to identify possible tapeworm carriers
among household members and other close personal con-
tacts. Treating such tapeworm carriers can eliminate
sources of infection and prevent additional transmission.
Controlled epidemiologic studies to assess risk factors and
potential sources for both local and travel-associated cases
of cysticercosis should be pursued. Although we could not
assess whether problems in access to health care con-
tributed to cysticercosis deaths, nearly 20% of persons with
fatal cases died at home, in an emergency room, or in an
outpatient setting. Studies to evaluate the possible impact
of access issues on cysticercosis deaths would be useful.
Collaborative studies with Mexican public health authori-
ties on the prevalence and incidence of cysticercosis in the
border regions should be implemented (24). While trans-
mission of cysticercosis from a commercial food handler
has never been documented such transmission may occur
and any food handler with taeniasis (infection with adult
T. solium or Taenia of unknown species) should be preclud-
ed from handling food until successfully treated. 
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